PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för gabapentin enacarbil. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

24 hits

Bibliografisk träff 2012-09-03

European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society.

Garcia-Borreguero D, Ferini-Strambi L, Kohnen R, O'Keeffe S, Trenkwalder C, Högl B, Benes H, Jennum P, Partinen M, Fer D, Montagna P, Bassetti CL, Iranzo A, Sonka K, Williams AM, European Federation of Neurological Societies, European Neurological Society, European Sleep Research Society.

Eur J Neurol · research support, non-u.s. gov't; practice guideline; journal article · DOI 10.1111/j.1468-1331.2012.03853.x

Bibliografisk träff 2012-09-01

Dose response of Gabapentin Enacarbil versus placebo in subjects with moderate-to-severe primary restless legs syndrome: an integrated analysis of three 12-week studies.

VanMeter SA, Kavanagh ST, Warren S, Barrett RW.

CNS Drugs · research support, non-u.s. gov't; journal article · DOI 10.2165/11634870-000000000-00000

Bibliografisk träff 2012-08-01

The treatment of restless legs syndrome and periodic limb movement disorder in adults--an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline.

Aurora RN, Kristo DA, Bista SR, Rowley JA, Zak RS, Casey KR, Lamm CI, Tracy SL, Rosenberg RS, American Academy of Sleep Medicine.

Sleep · meta-analysis; research-article; systematic review; practice guideline; journal article · DOI 10.5665/sleep.1988

Bibliografisk träff 2012-08-01

[Pharmacological and clinical profile of gabapentin enacarbil: a novel drug for the treatment of restless legs syndrome].

Kakimoto S, Ozawa T, Igarashi K, Tokuno T, Kaku S, Seki N.

Nihon Yakurigaku Zasshi · review; journal article · DOI 10.1254/fpj.140.85

Bibliografisk träff 2012-07-01

A randomized, double-blind, placebo-controlled, dose-response study to assess the pharmacokinetics, efficacy, and safety of gabapentin enacarbil in subjects with restless legs syndrome.

Lal R, Ellenbogen A, Chen D, Zomorodi K, Atluri H, Luo W, Tovera J, Hurt J, Bonzo D, Lassauzet ML, Vu A, Cundy KC.

Clin Neuropharmacol · research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1097/wnf.0b013e318259eac8

Bibliografisk träff 2012-05-01

Role of gabapentin enacarbil XR in restless legs syndrome.

Sivam S, Yee BJ.

Ther Clin Risk Manag · review-article; journal article · DOI 10.2147/tcrm.s24436

Bibliografisk träff 2012-02-01

Evaluation of gabapentin enacarbil on cardiac repolarization: a randomized, double-blind, placebo- and active-controlled, crossover thorough QT/QTc study in healthy adults.

Chen D, Lal R, Zomorodi K, Atluri H, Ho J, Luo W, Tovera J, Bonzo D, Cundy K.

Clin Ther · clinical trial, phase i; randomized controlled trial; journal article · DOI 10.1016/j.clinthera.2012.01.002

Bibliografisk träff 2012-01-31

Gabapentin enacarbil for treatment of restless legs syndrome in adults.

Hayes WJ, Lemon MD, Farver DK.

Ann Pharmacother · review; journal article · DOI 10.1345/aph.1q578

Bibliografisk träff 2011-12-28

Clinical pharmacokinetics of gabapentin after administration of gabapentin enacarbil extended-release tablets in patients with varying degrees of renal function using data from an open-label, single-dose pharmacokinetic study.

Lal R, Sukbuntherng J, Luo W, Chen D, Blumenthal R, Ho J, Cundy KC.

Clin Ther · multicenter study; clinical trial, phase i; journal article · DOI 10.1016/j.clinthera.2011.12.004

Bibliografisk träff 2011-11-14

Gabapentin enacarbil for the treatment of restless legs syndrome (RLS).

Burke RA, Faulkner MA.

Expert Opin Pharmacother · review; journal article · DOI 10.1517/14656566.2011.635645

Bibliografisk träff 2011-10-19

Long-term efficacy and safety of gabapentin enacarbil in Japanese restless legs syndrome patients.

Inoue Y, Uchimura N, Kuroda K, Hirata K, Hattori N.

Prog Neuropsychopharmacol Biol Psychiatry · clinical trial; research support, non-u.s. gov't; multicenter study; journal article · DOI 10.1016/j.pnpbp.2011.10.009

Bibliografisk träff 2011-09-01

Gabapentin encarbil (Horizant) for restless leg syndrome.

Författaruppgift saknas

Med Lett Drugs Ther · journal article

Bibliografisk träff 2011-06-01

A randomized, double-blind, placebo-controlled study to assess the efficacy and tolerability of gabapentin enacarbil in subjects with restless legs syndrome.

Lee DO, Ziman RB, Perkins AT, Poceta JS, Walters AS, Barrett RW, XP053 Study Group.

J Clin Sleep Med · research support, non-u.s. gov't; research-article; multicenter study; randomized controlled trial; journal article · DOI 10.5664/jcsm.1074

Bibliografisk träff 2011-05-31

Efficacy of gabapentin enacarbil vs placebo in patients with postherpetic neuralgia and a pharmacokinetic comparison with oral gabapentin.

Backonja MM, Canafax DM, Cundy KC.

Pain Med · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1111/j.1526-4637.2011.01139.x

Bibliografisk träff 2011-05-24

Randomized polysomnography study of gabapentin enacarbil in subjects with restless legs syndrome.

Winkelman JW, Bogan RK, Schmidt MH, Hudson JD, DeRossett SE, Hill-Zabala CE.

Mov Disord · research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1002/mds.23771

Bibliografisk träff 2011-04-28

Validation of the post sleep questionnaire for assessing subjects with restless legs syndrome: results from two double-blind, multicenter, placebo-controlled clinical trials.

Canafax DM, Bhanegaonkar A, Bharmal M, Calloway M.

BMC Neurol · research support, non-u.s. gov't; research-article; validation study; multicenter study; randomized controlled trial; journal article · DOI 10.1186/1471-2377-11-48

Bibliografisk träff 2011-02-01

A phase I, single-dose study of the disposition of 14C-radiolabeled gabapentin enacarbil in healthy male volunteers.

Lal R, Sukbuntherng J, Ho J, Cundy KC.

Int J Clin Pharmacol Ther · clinical trial, phase i; journal article · DOI 10.5414/cpp49109

Bibliografisk träff 2011-01-01

A 52-week study of gabapentin enacarbil in restless legs syndrome.

Ellenbogen AL, Thein SG, Winslow DH, Becker PM, Tolson JM, Lassauzet ML, Chen D.

Clin Neuropharmacol · research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1097/wnf.0b013e3182087d48

Bibliografisk träff 2011-01-01

Restless legs syndrome in children: a review and update on pharmacological options.

Frenette E.

Curr Pharm Des · review; journal article · DOI 10.2174/138161211796197142

Bibliografisk träff 2010-09-01

The use of gabapentin enacarbil in the treatment of restless legs syndrome.

Yaltho TC, Ondo WG.

Ther Adv Neurol Disord · review-article; journal article · DOI 10.1177/1756285610378059

Bibliografisk träff 2010-08-01

Gabapentin enacarbil (XP13512/GSK1838262) as an alternative treatment to dopaminergic agents for restless legs syndrome.

Imamura S, Kushida C.

Expert Opin Pharmacother · review; journal article · DOI 10.1517/14656566.2010.494598

Bibliografisk träff 2010-06-01

Long-term maintenance treatment of restless legs syndrome with gabapentin enacarbil: a randomized controlled study.

Bogan RK, Bornemann MA, Kushida CA, Trân PV, Barrett RW, XP060 Study Group.

Mayo Clin Proc · research support, non-u.s. gov't; research-article; randomized controlled trial; journal article · DOI 10.4065/mcp.2009.0700

Bibliografisk träff 2010-05-01

Clinical pharmacokinetic drug interaction studies of gabapentin enacarbil, a novel transported prodrug of gabapentin, with naproxen and cimetidine.

Lal R, Sukbuntherng J, Luo W, Vicente V, Blumenthal R, Ho J, Cundy KC.

Br J Clin Pharmacol · research support, non-u.s. gov't; research-article; journal article · DOI 10.1111/j.1365-2125.2010.03616.x

Bibliografisk träff 2010-01-01

Gabapentin enacarbil in restless legs syndrome.

Merlino G, Serafini A, Lorenzut S, Sommaro M, Gigli GL, Valente M.

Drugs Today (Barc) · review; journal article · DOI 10.1358/dot.2010.46.1.1424766